Form4insider filings, from the source

SEC Form 4 · accession 0001209191-18-057493

TEVA PHARMACEUTICAL INDUSTRIES LTD · TEVA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael James McClellan
Officer — EVP, Chief Financial Officer
Period of report
Nov 5, 2018
Accepted (ET)
Nov 7, 2018 · 6:38 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000818686

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Ordinary SharesF1,F2Nov 5, 2018M695—A11,990D
Ordinary SharesF1,F4Nov 5, 2018S346$22.7316D11,644D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Share UnitsF2,F5,F1—Nov 5, 2018M695D——Ordinary Shares695695D

Explanation of responses